THERMO FISHER SCIENTIFIC Unternehmen Thermo Fisher Scientific Berne S.E.
Aktien
857209
US8835561023
TFS
Medizinische Ausrüstung
|
Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 514.5 CHF | -0.35% |
|
-0.35% | +19.58% |
Kurzporträt
- Laborausrüstungen (70%). Darüber hinaus bietet die Gruppe chemische Produkte (Reagenzien, Lösungsmittel, Salze usw.), Verbrauchsmaterialien (Röhrchen, Trichter, Fläschchen usw.) sowie Konditionierung, Lagerung usw. an;
- Diagnostikgeräte und -produkte (15,3%);
- wissenschaftliche Analysegeräte (14,7%): Analysatoren (für Wasser, Gase, Böden usw.), Massenspektrometer, Molekülspektroskope, Mikroskope, Manometer, Probennehmer, mikrobiologische Geräte, reaktive Substanzen usw.
Der Nettoumsatz gliedert sich nach Einnahmequellen in Produktverkäufe (78,5%) und Dienstleistungen (21,5%).
Die Nettoumsätze teilen sich geographisch wie folgt auf: Nordamerika (53%), Europa (25,7%), Asien-Pazifik (18,1%) und Sonstige (3,2%).
Umsatz nach Geschäftsbereich
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Laboratory Products and Biopharma Services
53,8
%
| 22 511 | 50,1 % | 23 041 | 53,8 % | +2.35% |
Life Sciences Solutions
23,3
%
| 13 532 | 30,1 % | 9 977 | 23,3 % | -26.27% |
Analytical Instruments
16,9
%
| 6 624 | 14,7 % | 7 263 | 16,9 % | +9.65% |
Specialty Diagnostics
10,3
%
| 4 763 | 10,6 % | 4 405 | 10,3 % | -7.52% |
Eliminations
-4,3
%
| -2 515 | -5,6 % | -1 829 | -4,3 % | -27.28% |
Umsatz je Region
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
United States
51,4
%
| 23 820 | 53,0 % | 22 013 | 51,4 % | -7.59% |
Europe
25,1
%
| 10 762 | 24,0 % | 10 741 | 25,1 % | -0.20% |
Asia-Pacific
18,4
%
| 4 322 | 9,6 % | 7 873 | 18,4 % | +82.16% |
Other Regions
3,5
%
| 1 444 | 3,2 % | 1 479 | 3,5 % | +2.42% |
North America
1,8
%
| 774 | 1,7 % | 751 | 1,8 % | -2.97% |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01.11.01 |
| Director of Finance/CFO | 57 | 01.06.01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.19 |
Michel Lagarde
COO | Chief Operating Officer | 50 | 01.08.17 |
Karen Nelson
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alan Sachs
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.16 |
Rafael Tejada
IRC | Investor Relations Contact | - | 01.07.15 |
Frederick Lowery
PRN | Corporate Officer/Principal | 53 | 01.01.05 |
Mike Shafer
PRN | Corporate Officer/Principal | - | 01.01.09 |
Daniella Cramp
PRN | Corporate Officer/Principal | 50 | 01.10.19 |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01.11.01 |
C. Harris
BRD | Director/Board Member | 67 | 30.03.12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01.03.22 |
Scott Sperling
BRD | Director/Board Member | 66 | 09.11.06 |
| Director/Board Member | 69 | 14.07.11 | |
Nelson Chai
BRD | Director/Board Member | 58 | 10.12.10 |
Tyler Jacks
BRD | Director/Board Member | 63 | 26.05.09 |
Jenny Johnson
BRD | Director/Board Member | 59 | 13.07.23 |
R. Keith
BRD | Director/Board Member | 56 | 20.11.20 |
Dion Weisler
BRD | Director/Board Member | 56 | 01.03.17 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 442 822 699 | 381 015 311 ( 86,04 %) | 61 106 376 ( 13,80 %) | 86,04 % |
Unternehmensbesitz
| Name | Aktien | % | Bewertung |
|---|---|---|---|
AIFORIA TECHNOLOGIES OYJ 7,55% | 1 959 200 | 7,55% | 8 065 262 $ |
Unternehmenskontakt
Thermo Fisher Scientific, Inc.
168 Third Avenue
02451, Waltham
+781 622 1000
http://www.thermofisher.com
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Thermo Fisher Scientific India Pvt Ltd.
 Thermo Fisher Scientific India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2000, Thermo Fisher Scientific India Pvt Ltd. is a subsidiary of Thermo Fisher Scientific, Inc. The company is based in Mumbai, India. The Indian company enables its customers to make the world healthier, cleaner, and safer. |
Pharmaceuticals: Major
|
Power Sweden Holdings II AB
 Power Sweden Holdings II AB Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Power Sweden Holdings II AB is an investment holding Swedish company. The company is located in Sweden. |
Financial Conglomerates
|
Fisher BioPharma Services (India) Pvt Ltd.
 Fisher BioPharma Services (India) Pvt Ltd. Medical SpecialtiesHealth Technology Founded in 2006, Fisher BioPharma Services (India) Pvt Ltd. is a subsidiary of Thermo Fisher Scientific, Inc. The company is based in Sanand, India. The Indian company manufactures electromedical and electrotherapeutic apparatus. |
Medical Specialties
|
Life Technologies Finance Ltd.
 Life Technologies Finance Ltd. Regional BanksFinance Part of Thermo Fisher Scientific, Inc., Life Technologies Finance Ltd. provides banking and financial services. The company is based in Paisley, UK. Founded in 2011. |
Regional Banks
|
Oxoid International Ltd.
 Oxoid International Ltd. Medical DistributorsDistribution Services Part of Thermo Fisher Scientific, Inc., Oxoid International Ltd. is a holding British company that offers diagnostic products to microbiology laboratories. The company is based in Altrincham, UK. |
Medical Distributors
|
Trustees of The Thermo Fisher Scientific DB Pension Scheme
|
Investment Managers
|
Thermo Fisher Scientific Brno sro
| |
Erie UK 3 Ltd.
 Erie UK 3 Ltd. Finance/Rental/LeasingFinance Part of Thermo Fisher Scientific, Inc., Erie UK 3 Ltd. is a financing company. The company is based in Altrincham, UK. Erie UK 3 was founded in 2018. |
Finance/Rental/Leasing
|
FEI Deutschland GmbH
 FEI Deutschland GmbH Wholesale DistributorsDistribution Services Part of Thermo Fisher Scientific, Inc., FEI Deutschland GmbH is a German company that specializes in electron microscopes. The company is based in Dreieich, Germany and the CEO of the company is Markus Wild. The company's microscopes use electrons to create images that magnify micrometer and nanometer structures by up to ten million times, providing a level of detail that allows researchers to view single atoms. |
Wholesale Distributors
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
| % 1. Jan. | Kap. | |
|---|---|---|
| +14.90% | 197 Mrd. | |
| +18.22% | 141 Mrd. | |
| +29.15% | 110 Mrd. | |
| +0.53% | 64.15 Mrd. | |
| +16.92% | 53.72 Mrd. | |
| +6.33% | 51.75 Mrd. | |
| +10.93% | 45.2 Mrd. | |
| +5.87% | 37.37 Mrd. | |
| +27.06% | 32.11 Mrd. |
- Börse
- Aktien
- 857209 Aktie
- 857209 Aktie
- Unternehmen Thermo Fisher Scientific
